Safety and tolerability of regadenoson in 514 SPECT MPI patients with and without coronary artery disease and submaximal exercise heart rate response
2012 ◽
Vol 40
(3)
◽
pp. 341-348
◽
Keyword(s):
2012 ◽
Vol 15
(3)
◽
pp. 162-170
◽
Keyword(s):
Keyword(s):
Keyword(s):
2017 ◽
Vol 228
◽
pp. 114-121
◽
2006 ◽
Vol 40
(9)
◽
pp. 773-778
◽
1995 ◽
Vol 76
(10)
◽
pp. 657-660
◽
Keyword(s):
Keyword(s):
1993 ◽
Vol 72
(18)
◽
pp. 1376-1382
◽
Keyword(s):
1998 ◽
Vol 31
◽
pp. 46
Keyword(s):
Keyword(s):